Literature DB >> 11208592

Basal forebrain acetylcholine release during REM sleep is significantly greater than during waking.

J Vazquez1, H A Baghdoyan.   

Abstract

Cholinergic neurons of the basal forebrain supply the neocortex with ACh and play a major role in regulating behavioral arousal and cortical electroencephalographic activation. Cortical ACh release is greatest during waking and rapid eye movement (REM) sleep and reduced during non-REM (NREM) sleep. Loss of basal forebrain cholinergic neurons contributes to sleep disruption and to the cognitive deficits of many neurological disorders. ACh release within the basal forebrain previously has not been quantified during sleep. This study used in vivo microdialysis to test the hypothesis that basal forebrain ACh release varies as a function of sleep and waking. Cats were trained to sleep in a head-stable position, and dialysis samples were collected during polygraphically defined states of waking, NREM sleep, and REM sleep. Results from 22 experiments in four animals demonstrated that means +/- SE ACh release (pmol/10 min) was greatest during REM sleep (0.77 +/- 0.07), intermediate during waking (0.58 +/- 0.03), and lowest during NREM sleep (0.34 +/- 0.01). The finding that, during REM sleep, basal forebrain ACh release is significantly elevated over waking levels suggests a differential role for basal forebrain ACh during REM sleep and waking.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11208592     DOI: 10.1152/ajpregu.2001.280.2.R598

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  36 in total

1.  Neuropharmacology of Sleep and Wakefulness.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2010-12

Review 2.  Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention.

Authors:  J Fadel; J A Burk
Journal:  Brain Res       Date:  2009-08-21       Impact factor: 3.252

3.  A distinct class of slow (~0.2-2 Hz) intrinsically bursting layer 5 pyramidal neurons determines UP/DOWN state dynamics in the neocortex.

Authors:  Magor L Lőrincz; David Gunner; Ying Bao; William M Connelly; John T R Isaac; Stuart W Hughes; Vincenzo Crunelli
Journal:  J Neurosci       Date:  2015-04-08       Impact factor: 6.167

Review 4.  Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.

Authors:  Chanung Wang; David M Holtzman
Journal:  Neuropsychopharmacology       Date:  2019-08-13       Impact factor: 7.853

Review 5.  Escape From Oblivion: Neural Mechanisms of Emergence From General Anesthesia.

Authors:  Max B Kelz; Paul S García; George A Mashour; Ken Solt
Journal:  Anesth Analg       Date:  2019-04       Impact factor: 5.108

6.  GABA-to-ACh ratio in basal forebrain and cerebral cortex varies significantly during sleep.

Authors:  Giancarlo Vanini; Ralph Lydic; Helen A Baghdoyan
Journal:  Sleep       Date:  2012-10-01       Impact factor: 5.849

7.  Innervation of orexin/hypocretin neurons by GABAergic, glutamatergic or cholinergic basal forebrain terminals evidenced by immunostaining for presynaptic vesicular transporter and postsynaptic scaffolding proteins.

Authors:  Pablo Henny; Barbara E Jones
Journal:  J Comp Neurol       Date:  2006-12-01       Impact factor: 3.215

Review 8.  The neurobiological basis of sleep: Insights from Drosophila.

Authors:  Sarah Ly; Allan I Pack; Nirinjini Naidoo
Journal:  Neurosci Biobehav Rev       Date:  2018-01-31       Impact factor: 8.989

Review 9.  Overnight therapy? The role of sleep in emotional brain processing.

Authors:  Matthew P Walker; Els van der Helm
Journal:  Psychol Bull       Date:  2009-09       Impact factor: 17.737

10.  The nitric oxide synthase inhibitor NG-Nitro-L-arginine increases basal forebrain acetylcholine release during sleep and wakefulness.

Authors:  Jacqueline Vazquez; Ralph Lydic; Helen A Baghdoyan
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.